These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26958710)

  • 81. Practical Model Selection for Prospective Virtual Screening.
    Liu S; Alnammi M; Ericksen SS; Voter AF; Ananiev GE; Keck JL; Hoffmann FM; Wildman SA; Gitter A
    J Chem Inf Model; 2019 Jan; 59(1):282-293. PubMed ID: 30500183
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Optimization of high throughput virtual screening by combining shape-matching and docking methods.
    Lee HS; Choi J; Kufareva I; Abagyan R; Filikov A; Yang Y; Yoon S
    J Chem Inf Model; 2008 Mar; 48(3):489-97. PubMed ID: 18302357
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Improving Screening Efficiency through Iterative Screening Using Docking and Conformal Prediction.
    Svensson F; Norinder U; Bender A
    J Chem Inf Model; 2017 Mar; 57(3):439-444. PubMed ID: 28195474
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Selection of in silico drug screening results for G-protein-coupled receptors by using universal active probes.
    Wada M; Kanamori E; Nakamura H; Fukunishi Y
    J Chem Inf Model; 2011 Sep; 51(9):2398-407. PubMed ID: 21848279
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Structure versus function-The impact of computational methods on the discovery of specific GPCR-ligands.
    Bermudez M; Wolber G
    Bioorg Med Chem; 2015 Jul; 23(14):3907-12. PubMed ID: 25828056
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Challenging Reverse Screening: A Benchmark Study for Comprehensive Evaluation.
    Li M; Hu J; Wang Y; Li Y; Zhang L; Liu Z
    Mol Inform; 2022 Apr; 41(4):e2100063. PubMed ID: 34787366
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Ligand and decoy sets for docking to G protein-coupled receptors.
    Gatica EA; Cavasotto CN
    J Chem Inf Model; 2012 Jan; 52(1):1-6. PubMed ID: 22168315
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Docking of peptides to GPCRs using a combination of CABS-dock with FlexPepDock refinement.
    Badaczewska-Dawid AE; Kmiecik S; Koliński M
    Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32520310
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Fragment-Based Analysis of Ligand Dockings Improves Classification of Actives.
    Belew RK; Forli S; Goodsell DS; O'Donnell TJ; Olson AJ
    J Chem Inf Model; 2016 Aug; 56(8):1597-607. PubMed ID: 27384036
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Identification of free fatty acid receptor 2 agonists using virtual screening.
    Fells JI; Ai X; Weinglass A; Feng W; Lei Y; Finley M; Hoveyda HR; Fraser GL; Machacek M
    Bioorg Med Chem Lett; 2020 Nov; 30(21):127460. PubMed ID: 32755680
    [TBL] [Abstract][Full Text] [Related]  

  • 91. DecoyFinder: an easy-to-use python GUI application for building target-specific decoy sets.
    Cereto-Massagué A; Guasch L; Valls C; Mulero M; Pujadas G; Garcia-Vallvé S
    Bioinformatics; 2012 Jun; 28(12):1661-2. PubMed ID: 22539671
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Benchmarking Refined and Unrefined AlphaFold2 Structures for Hit Discovery.
    Zhang Y; Vass M; Shi D; Abualrous E; Chambers JM; Chopra N; Higgs C; Kasavajhala K; Li H; Nandekar P; Sato H; Miller EB; Repasky MP; Jerome SV
    J Chem Inf Model; 2023 Mar; 63(6):1656-1667. PubMed ID: 36897766
    [TBL] [Abstract][Full Text] [Related]  

  • 93. vSDC: a method to improve early recognition in virtual screening when limited experimental resources are available.
    Chaput L; Martinez-Sanz J; Quiniou E; Rigolet P; Saettel N; Mouawad L
    J Cheminform; 2016; 8():1. PubMed ID: 26807156
    [TBL] [Abstract][Full Text] [Related]  

  • 94. RADER: a RApid DEcoy Retriever to facilitate decoy based assessment of virtual screening.
    Wang L; Pang X; Li Y; Zhang Z; Tan W
    Bioinformatics; 2017 Apr; 33(8):1235-1237. PubMed ID: 28011765
    [TBL] [Abstract][Full Text] [Related]  

  • 95. DOCKSTRING: Easy Molecular Docking Yields Better Benchmarks for Ligand Design.
    García-Ortegón M; Simm GNC; Tripp AJ; Hernández-Lobato JM; Bender A; Bacallado S
    J Chem Inf Model; 2022 Aug; 62(15):3486-3502. PubMed ID: 35849793
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Discovery of Covalent Ligands via Noncovalent Docking by Dissecting Covalent Docking Based on a "Steric-Clashes Alleviating Receptor (SCAR)" Strategy.
    Ai Y; Yu L; Tan X; Chai X; Liu S
    J Chem Inf Model; 2016 Aug; 56(8):1563-75. PubMed ID: 27411028
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Ligand Strain Energy in Large Library Docking.
    Gu S; Smith MS; Yang Y; Irwin JJ; Shoichet BK
    J Chem Inf Model; 2021 Sep; 61(9):4331-4341. PubMed ID: 34467754
    [TBL] [Abstract][Full Text] [Related]  

  • 98. DUBS: A Framework for Developing
    Fine J; Muhoberac M; Fraux G; Chopra G
    J Chem Inf Model; 2020 Sep; 60(9):4137-4143. PubMed ID: 32639154
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Benchmarking Data Sets from PubChem BioAssay Data: Current Scenario and Room for Improvement.
    Tran-Nguyen VK; Rognan D
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575564
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Property-Unmatched Decoys in Docking Benchmarks.
    Stein RM; Yang Y; Balius TE; O'Meara MJ; Lyu J; Young J; Tang K; Shoichet BK; Irwin JJ
    J Chem Inf Model; 2021 Feb; 61(2):699-714. PubMed ID: 33494610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.